COCP
Price
$1.03
Change
-$0.07 (-6.36%)
Updated
Nov 13 closing price
Capitalization
14.33M
Intraday BUY SELL Signals
VKTX
Price
$39.00
Change
-$1.78 (-4.36%)
Updated
Nov 13 closing price
Capitalization
4.41B
89 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COCP vs VKTX

Header iconCOCP vs VKTX Comparison
Open Charts COCP vs VKTXBanner chart's image
Cocrystal Pharma
Price$1.03
Change-$0.07 (-6.36%)
Volume$46.44K
Capitalization14.33M
Viking Therapeutics
Price$39.00
Change-$1.78 (-4.36%)
Volume$3.83M
Capitalization4.41B
COCP vs VKTX Comparison Chart in %
View a ticker or compare two or three
VS
COCP vs. VKTX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COCP is a StrongBuy and VKTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (COCP: $1.10 vs. VKTX: $40.78)
Brand notoriety: COCP and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COCP: 3% vs. VKTX: 112%
Market capitalization -- COCP: $14.33M vs. VKTX: $4.41B
COCP [@Biotechnology] is valued at $14.33M. VKTX’s [@Biotechnology] market capitalization is $4.41B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COCP’s FA Score shows that 0 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • COCP’s FA Score: 0 green, 5 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, VKTX is a better buy in the long-term than COCP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COCP’s TA Score shows that 6 TA indicator(s) are bullish while VKTX’s TA Score has 6 bullish TA indicator(s).

  • COCP’s TA Score: 6 bullish, 2 bearish.
  • VKTX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, COCP is a better buy in the short-term than VKTX.

Price Growth

COCP (@Biotechnology) experienced а +5.77% price change this week, while VKTX (@Biotechnology) price change was +11.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

VKTX is expected to report earnings on Feb 11, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($4.41B) has a higher market cap than COCP($14.3M). VKTX YTD gains are higher at: 1.342 vs. COCP (-45.545). COCP has higher annual earnings (EBITDA): -12.3M vs. VKTX (-212.42M). VKTX has more cash in the bank: 808M vs. COCP (4.77M). VKTX has less debt than COCP: VKTX (878K) vs COCP (1.66M). COCP (0) and VKTX (0) have equivalent revenues.
COCPVKTXCOCP / VKTX
Capitalization14.3M4.41B0%
EBITDA-12.3M-212.42M6%
Gain YTD-45.5451.342-3,394%
P/E RatioN/AN/A-
Revenue00-
Total Cash4.77M808M1%
Total Debt1.66M878K189%
FUNDAMENTALS RATINGS
COCP vs VKTX: Fundamental Ratings
COCP
VKTX
OUTLOOK RATING
1..100
2517
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
41
Fair valued
PROFIT vs RISK RATING
1..100
10068
SMR RATING
1..100
9894
PRICE GROWTH RATING
1..100
8345
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
4850

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VKTX's Valuation (41) in the Biotechnology industry is in the same range as COCP (73) in the Pharmaceuticals Generic industry. This means that VKTX’s stock grew similarly to COCP’s over the last 12 months.

VKTX's Profit vs Risk Rating (68) in the Biotechnology industry is in the same range as COCP (100) in the Pharmaceuticals Generic industry. This means that VKTX’s stock grew similarly to COCP’s over the last 12 months.

VKTX's SMR Rating (94) in the Biotechnology industry is in the same range as COCP (98) in the Pharmaceuticals Generic industry. This means that VKTX’s stock grew similarly to COCP’s over the last 12 months.

VKTX's Price Growth Rating (45) in the Biotechnology industry is somewhat better than the same rating for COCP (83) in the Pharmaceuticals Generic industry. This means that VKTX’s stock grew somewhat faster than COCP’s over the last 12 months.

COCP's P/E Growth Rating (99) in the Pharmaceuticals Generic industry is in the same range as VKTX (100) in the Biotechnology industry. This means that COCP’s stock grew similarly to VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COCPVKTX
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 18 days ago
83%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 23 days ago
88%
Bearish Trend 10 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
COCP
Daily Signal:
Gain/Loss:
VKTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YOU38.140.89
+2.39%
Clear Secure
VIR5.71N/A
N/A
Vir Biotechnology
BVFL16.85-0.10
-0.59%
BV Financial
LYV140.49-1.36
-0.96%
Live Nation Entertainment
GENK2.66-0.09
-3.27%
GEN Restaurant Group

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with SYRE. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
+0.44%
SYRE - VKTX
45%
Loosely correlated
+0.34%
NEVPF - VKTX
45%
Loosely correlated
N/A
GPCR - VKTX
43%
Loosely correlated
+3.03%
IMTX - VKTX
42%
Loosely correlated
+16.10%
RGNX - VKTX
40%
Loosely correlated
+0.43%
More